You are here

RSV

GSK, Pfizer RSV Shots Must Warn About Rare Paralysis Risk

Mint

Tue, 01/7/25 - 06:56 pm

Guillain-Barré Syndrome

After tough year, Moderna CEO confronts challenges for RSV, COVID businesses in shareholder letter

Fierce Pharma

Tue, 01/7/25 - 11:43 am

Moderna Therapeutics

Stephane Bancel

Merck targets 2025 RSV season with antibody now under FDA review

BioPharma Dive

Wed, 12/18/24 - 11:09 am

After Moderna's pediatric RSV vaccine trial hold, expert panel says more testing is needed

Fierce Pharma

Fri, 12/13/24 - 11:38 am

Moderna Therapeutics

clinical trials

Enanta's RSV antiviral reduces viral load in phase 2 pediatric study

Fierce Biotech

Mon, 12/9/24 - 11:03 am

Enanta Pharmaceuticals

clinical trials

ArkBio concludes dosing for RSV prevention trial in infants

Clinical Trials Arena

Mon, 11/25/24 - 11:07 am

clinical trials

Dyadic receives grant from Gates Foundation for RSV antibody development

Pharmaceutical Business Review

Fri, 11/22/24 - 11:15 am

Gates Foundation

monoclonal antibodies

CDC expects COVID and RSV levels to increase in coming weeks

Reuters

Wed, 11/20/24 - 08:36 pm

Cases hit pre-COVID lows as virus season begins

Axios

Thu, 11/14/24 - 10:00 am

Moderna posts surprise profit as Covid vaccine sales impress, cost cuts take hold

CNBC

Thu, 11/7/24 - 11:33 am

Moderna Therapeutics

GSK’s RSV vaccine approved in Canada for adults aged 50 to 59

Pharmaceutical Technology

Wed, 11/6/24 - 08:04 pm

GSK tries to steady the ship as Arexvy sales plummet in wake of CDC guidance changes

Fierce Pharma

Wed, 10/30/24 - 11:47 am

GSK answers Pfizer's RSV approval with data targeting matching nod in younger adults

Fierce Pharma

Thu, 10/24/24 - 10:58 am

Merck's RSV antibody for infants shows over 60% efficacy in mid-late-stage study

Reuters

Thu, 10/17/24 - 08:39 pm

clinical trials

'Ongoing challenges' force Pfizer to scrap oral RSV med from ReViral buyout

Fierce Biotech

Tue, 10/8/24 - 09:54 pm

GSK says RSV vaccine protects against disease over three seasons

BioPharma Dive

Tue, 10/8/24 - 09:47 pm

clinical trials

GSK, Pfizer RSV vaccine sales fall in US as millions fewer people line up

Reuters

Tue, 10/8/24 - 11:17 am

Pfizer wins bid to invalidate GSK's patents over RSV vaccine

Reuters

Mon, 10/7/24 - 11:53 am

Thermo Fisher's plant making infant RSV drug breached FDA rules, documents show

Reuters

Fri, 10/4/24 - 09:22 am

drug manufacturing

WHO recommends maternal vaccine and antibody shot to prevent RSV in infants

Reuters

Tue, 10/1/24 - 10:17 pm

Pages